MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TVGNW had -$730,623 decrease in cash & cash equivalents over the period. -$12,393,016 in free cash flow.

Cash Flow Overview

Change in Cash
-$730,623
Free Cash flow
-$12,393,016
Unit: Dollar
Positive Cash Flow Breakdown
    • Stock-based compensation expense
    • Proceeds from issuance of shares...
    • Capital contribution
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accounts payable
    • Other assets
    • Others

Cash Flow
2025-12-31
Non-cash interest expense
0
Merger transaction costs
0
Change in fair value of convertible promissory notes
0
Loss on series a preferred stock issuance
0
Loss on issuance of commitment shares
0
Stock-based compensation expense
16,222,861
Change in fair value of warrants
-60,701
Amortization of right-of-use asset
318,624
Prepaid expenses and other assets
-101,838
Other assets
490,043
Accounts payable
-1,964,118
Accrued expenses and other liabilities
-74,203
Operating lease liabilities
-297,976
Depreciation expense
190,573
Net loss
-26,275,432
Net cash used in operating activities
-12,328,577
Purchases of property and equipment
64,439
Net cash used in investing activities
-64,439
Cash acquired in connection with the reverse recapitalization
0
Proceeds from issuance of series a preferred stock
0
Proceeds from issuance of series c preferred stock
0
Nonrefundable prepaid proceeds towards anticipated series a-1 preferred stock issuance
0
Proceeds from loan agreement
3,400,000
Payment of offering costs associated with the sales agreement
100,000
Proceeds from issuance of shares under the sales agreement, net of offering costs
4,862,393
Capital contribution
3,500,000
Net cash provided by financing activities
11,662,393
Net (decrease) increase in cash
-730,623
Net (decrease) increase in cash
-730,623
Cash - beginning of period
1,282,995
Cash - end of period
552,372
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofshares under the sales...$4,862,393 Capital contribution$3,500,000 Proceeds from loanagreement$3,400,000 Net (decrease)increase in cash-$730,623 Net cash provided byfinancing activities$11,662,393 Canceled cashflow$100,000 Net (decrease)increase in cash-$730,623 Canceled cashflow$11,662,393 Stock-based compensationexpense$16,222,861 Amortization of right-of-useasset$318,624 Depreciation expense$190,573 Prepaid expenses andother assets-$101,838 Payment of offeringcosts associated with...$100,000 Net cash used inoperating activities-$12,328,577 Canceled cashflow$16,833,896 Net cash used ininvesting activities-$64,439 Net loss-$26,275,432 Accounts payable-$1,964,118 Other assets$490,043 Operating leaseliabilities-$297,976 Accrued expenses andother liabilities-$74,203 Change in fair value ofwarrants-$60,701 Purchases of property andequipment$64,439

Tevogen Bio Holdings Inc. (TVGNW)

Tevogen Bio Holdings Inc. (TVGNW)